1. Home
  2. BFLY vs NYXH Comparison

BFLY vs NYXH Comparison

Compare BFLY & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFLY
  • NYXH
  • Stock Information
  • Founded
  • BFLY 2011
  • NYXH 2009
  • Country
  • BFLY United States
  • NYXH Belgium
  • Employees
  • BFLY N/A
  • NYXH N/A
  • Industry
  • BFLY Medical Electronics
  • NYXH Medical/Dental Instruments
  • Sector
  • BFLY Health Care
  • NYXH Health Care
  • Exchange
  • BFLY Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • BFLY 225.5M
  • NYXH 261.1M
  • IPO Year
  • BFLY N/A
  • NYXH 2021
  • Fundamental
  • Price
  • BFLY $3.30
  • NYXH $8.28
  • Analyst Decision
  • BFLY
  • NYXH Strong Buy
  • Analyst Count
  • BFLY 0
  • NYXH 5
  • Target Price
  • BFLY N/A
  • NYXH $17.00
  • AVG Volume (30 Days)
  • BFLY 3.8M
  • NYXH 27.0K
  • Earning Date
  • BFLY 11-01-2024
  • NYXH 11-06-2024
  • Dividend Yield
  • BFLY N/A
  • NYXH N/A
  • EPS Growth
  • BFLY N/A
  • NYXH N/A
  • EPS
  • BFLY N/A
  • NYXH N/A
  • Revenue
  • BFLY $76,221,000.00
  • NYXH $5,668,079.00
  • Revenue This Year
  • BFLY $24.93
  • NYXH $37.10
  • Revenue Next Year
  • BFLY $18.11
  • NYXH $418.12
  • P/E Ratio
  • BFLY N/A
  • NYXH N/A
  • Revenue Growth
  • BFLY 11.49
  • NYXH 32.65
  • 52 Week Low
  • BFLY $0.67
  • NYXH $4.00
  • 52 Week High
  • BFLY $3.55
  • NYXH $20.00
  • Technical
  • Relative Strength Index (RSI)
  • BFLY 77.19
  • NYXH 33.81
  • Support Level
  • BFLY $2.29
  • NYXH $8.02
  • Resistance Level
  • BFLY $2.92
  • NYXH $10.01
  • Average True Range (ATR)
  • BFLY 0.32
  • NYXH 0.48
  • MACD
  • BFLY 0.09
  • NYXH -0.15
  • Stochastic Oscillator
  • BFLY 98.60
  • NYXH 13.07

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: